Synthesis and in Vitro Evaluation of Selective CDK9 Inhibitors

被引：0
|
作者：
Shao, H. [1 ]
Abbas, A. Y. [1 ]
Shi, S. [1 ]
Foley, D. [1 ]
Huang, S. [1 ]
Bradshaw, T. D. [1 ]
Pepper, C. [2 ]
Endicott, J. A. [3 ,4 ]
Wang, S. [1 ]
Fischer, P. M. [1 ]
机构：
[1] Univ Nottingham, Div Med Chem & Struct Biol, Nottingham NG7 2RD, England
[2] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales
[3] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England
[4] Univ Oxford, Lab Mol Biophys, Oxford, England
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72072-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [1] Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy
    Alsfouk, Aisha A.
    Alshibl, Hanan M.
    Altwaijry, Najla A.
    Alsfouk, Bshra A.
    Al-Abdullah, Ebtehal S.
    MONATSHEFTE FUR CHEMIE, 2021, 152 (01): : 109 - 120
  • [2] Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy
    Aisha A. Alsfouk
    Hanan M. Alshibl
    Najla A. Altwaijry
    Bshra A. Alsfouk
    Ebtehal S. Al-Abdullah
    Monatshefte für Chemie - Chemical Monthly, 2021, 152 : 109 - 120
  • [3] Design, synthesis and anticancer evaluation of selective 2,4-disubstituted pyrimidine CDK9 inhibitors
    Xu, Zichen
    Zhang, Bin
    Liu, Zhikun
    Gou, Shaohua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [4] Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection
    Nemeth, G.
    Varga, Z.
    Greff, Z.
    Bencze, G.
    Sipos, A.
    Szantai-Kis, C.
    Baska, F.
    Gyuris, A.
    Kelemenics, K.
    Szathmary, Z.
    Minarovits, J.
    Keri, G.
    Orfi, L.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (03) : 342 - 358
  • [5] A patent review of selective CDK9 inhibitors in treating cancer
    Wu, Tizhi
    Wu, Xiaowei
    Xu, Yifan
    Chen, Rui
    Wang, Jubo
    Li, Zhiyu
    Bian, Jinlei
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2023, 33 (04) : 309 - 322
  • [6] Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
    Olson, Calla M.
    Jiang, Baishan
    Erb, Michael A.
    Liang, Yanke
    Doctor, Zainab M.
    Zhang, Zinan
    Zhang, Tinghu
    Kwiatkowski, Nicholas
    Boukhali, Myriam
    Green, Jennifer L.
    Haas, Wilhelm
    Nomanbhoy, Tyzoon
    Fischer, Eric S.
    Young, Richard A.
    Bradner, James E.
    Winter, Georg E.
    Gray, Nathanael S.
    NATURE CHEMICAL BIOLOGY, 2018, 14 (02) : 163 - +
  • [7] Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
    Olson C.M.
    Jiang B.
    Erb M.A.
    Liang Y.
    Doctor Z.M.
    Zhang Z.
    Zhang T.
    Kwiatkowski N.
    Boukhali M.
    Green J.L.
    Haas W.
    Nomanbhoy T.
    Fischer E.S.
    Young R.A.
    Bradner J.E.
    Winter G.E.
    Gray N.S.
    Nature Chemical Biology, 2018, 14 (2) : 163 - 170
  • [8] CDK9 inhibitor design, synthesis and biological evaluation
    Shi, Shenhua
    Liu, Xiangrui
    Lam, Fankie
    Wang, Shudong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1363 - 1363
  • [9] CDK9 inhibitors in cancer research
    Huang, Zhi
    Wang, Tianqi
    Wang, Cheng
    Fan, Yan
    RSC MEDICINAL CHEMISTRY, 2022, 13 (06): : 688 - 710
  • [10] Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors
    Nemeth, Gabor
    Greff, Zoltan
    Sipos, Anna
    Varga, Zoltan
    Szekely, Rita
    Sebestyen, Monika
    Jaszay, Zsuzsa
    Beni, Szabolcs
    Nemes, Zoltan
    Pirat, Jean-Luc
    Volle, Jean-Noel
    Virieux, David
    Gyuris, Agnes
    Kelemenics, Katalin
    Ay, Eva
    Minarovits, Janos
    Szathmary, Susan
    Keri, Gyoergy
    Orfi, Laszlo
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) : 3939 - 3965
12345